Eugene Washington, MD, chancellor for health affairs at Duke University and president and CEO of the Duke University Health System, and Nancy Andrews, MD, PhD, dean of the Duke University School of Medicine, today announced the launch of the Duke Clinical and Translational Science Institute (CTSI).
This Institute is an academic hub at Duke for accelerating the translation and implementation of scientific discoveries into health benefits for patients and communities. The Institute will be led by L. Ebony Boulware, MD, MPH, Vice Dean for Translational Sciences, Associate Vice Chancellor for Translational Research, Chief of the Division of General Internal Medicine, and co-Principal Investigator of Duke’s Clinical and Translational Science Award (CTSA) from the NIH.
Our goal is to serve as a catalyst for translational science by facilitating collaborations across Duke departments, institutes, schools, and the community that help us advance health together.
- Dr. Boulware